Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Latrepirdine

No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   



Living with Dementia

medicare1 - concept of dementia1 - cerebral parenchyma1 - prevent dementia4 - parkinson's7 - α-synuclein2 - mental function1 - mild tremor1 - cognitive ability1 - improved recognition1 - skin problems1 - mental faculties2 - tuberculosis1 - imbecility1 - amyloid beta 42 peptide1 - confabulatory euphoria1 - cognitive symptoms1 - parkinsons disease10 - dementia care program1 - signs of dementia6 - huntington's chorea1 - imbeciles1 - mind diet1 - risk of dementia12 - progressive neurodegenerative disorder1 - neel nabar1 - oxidative stress1 - socioeconomic boundaries1 - functional psychosis1 - personal care1 -